Insider Trading Alert - MCP, OPK And SFLY Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, April 22, 2014, 34 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $599.99 to $79,165,747.80.

Highlighted Stocks Traded by Insiders:

Molycorp (MCP) - FREE Research Report

Graell John, who is Director at Molycorp, bought 60,000 shares at $5.90 on April 22, 2014. Following this transaction, the Director owned 60,000 shares meaning that the stake was reduced by 100% with the 60,000-share transaction.

The shares most recently traded at $4.90, down $1.00, or 20.41% since the insider transaction. Historical insider transactions for Molycorp go as follows:

  • 4-Week # shares bought: 30,000
  • 12-Week # shares bought: 30,000
  • 24-Week # shares bought: 14.7 million

The average volume for Molycorp has been 4.5 million shares per day over the past 30 days. Molycorp has a market cap of $1.1 billion and is part of the basic materials sector and metals & mining industry. Shares are down 12.1% year-to-date as of the close of trading on Tuesday.

Molycorp, Inc. produces and sells rare earths and rare metal materials in the United States and internationally. Currently, there is 1 analyst who rates Molycorp a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MCP - FREE

TheStreet Quant Ratings rates Molycorp as a sell. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow, generally disappointing historical performance in the stock itself and generally high debt management risk. Get the full Molycorp Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al, who is CEO & Chairman at Opko Health, bought 100,000 shares at $8.32 on April 22, 2014. Following this transaction, the CEO & Chairman owned 140.4 million shares meaning that the stake was reduced by 0.07% with the 100,000-share transaction.

The shares most recently traded at $8.15, down $0.17, or 2.11% since the insider transaction. Historical insider transactions for Opko Health go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 46,730
  • 12-Week # shares bought: 20,000
  • 12-Week # shares sold: 46,730
  • 24-Week # shares bought: 40,000
  • 24-Week # shares sold: 46,730

The average volume for Opko Health has been 3.1 million shares per day over the past 30 days. Opko Health has a market cap of $3.5 billion and is part of the health care sector and health services industry. Shares are down 1.54% year-to-date as of the close of trading on Tuesday.

Opko Health, Inc., a biopharmaceutical and diagnostics company, is engaged in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently, there are 4 analysts who rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Shutterfly (SFLY) - FREE Research Report

Housenbold Jeffrey T, who is President & CEO at Shutterfly, sold 39,979 shares at $42.17 on April 22, 2014. Following this transaction, the President & CEO owned 289,021 shares meaning that the stake was reduced by 12.15% with the 39,979-share transaction.

The shares most recently traded at $41.55, down $0.62, or 1.49% since the insider transaction. Historical insider transactions for Shutterfly go as follows:

  • 4-Week # shares bought: 15,000
  • 4-Week # shares sold: 39,979
  • 12-Week # shares bought: 15,000
  • 12-Week # shares sold: 161,516
  • 24-Week # shares bought: 15,000
  • 24-Week # shares sold: 161,516

The average volume for Shutterfly has been 1.2 million shares per day over the past 30 days. Shutterfly has a market cap of $1.6 billion and is part of the services sector and diversified services industry. Shares are down 16.83% year-to-date as of the close of trading on Tuesday.

Shutterfly, Inc. is engaged in the manufacture and retail of digital personalized products and services in the United States. The company has a P/E ratio of 200.2. Currently, there are 6 analysts who rate Shutterfly a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SFLY - FREE

TheStreet Quant Ratings rates Shutterfly as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. Get the full Shutterfly Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Dow Tumbles as Trump Calls Off North Korea Summit

Dow Tumbles as Trump Calls Off North Korea Summit

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Stocks Could Easily Crater Into Memorial Day Weekend

Stocks Could Easily Crater Into Memorial Day Weekend

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Celgene Shares Rise on Plans to Increase Stock Buybacks

Celgene Shares Rise on Plans to Increase Stock Buybacks